Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory loss. Glycogen synthase kinase 3β (GSK-3β) plays a pivotal role in AD pathogenesis, particularly in tau protein hyperphosphorylation. Natural bioactive compounds have a wide range of so...
Saved in:
Main Authors: | Mei Wang, Wendi Huang, Juan Huang, Yong Luo, Nanqu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1497861/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
C/EBPβ in Alzheimer’s disease: An integrative regulator of pathological mechanisms
by: Xiaoting Luo, et al.
Published: (2025-02-01) -
Unveiling neurogenic biomarkers for the differentiation between sepsis patients with or without encephalopathy: an updated meta-analysis
by: Jiyun Hu, et al.
Published: (2025-02-01) -
NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3β/β-catenin pathway in hepatocellular carcinoma
by: Chao-Yan Yao, et al.
Published: (2025-02-01) -
Dynamic regimes in planetary cores: $\tau $–$\ell $ diagrams
by: Nataf, Henri-Claude, et al.
Published: (2024-05-01) -
Anti-TNBC effects of Lappaol F by targeting epithelial-mesenchymal transition via regulation of GSK-3β/YAP/β-catenin and PI3K/AKT pathways
by: Qiqi Meng, et al.
Published: (2025-02-01)